What Happened?
Calgary, AB-based XORTX Appointed David MacDonald as Chief Technology Officer
About the Company
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
About the Person
David MacDonald is Chief Technology Officer at XORTX. Previously, David held various senior IT leadership roles in the industry.
Info Source
News
Short Profile